No Data
Vitura Health Reports Successive Increases in Revenue in February, March, April; Shares Rise 3%
Vitura Health Ltd: Q3 FY2025 business update
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Vitura Health Limited Announces Director's Interest Change
Vitura Health Ltd: Investor webinar and presentation
Vitura Health Ltd: H1 FY2025 financial results
151820638 : In six months, it will be clear how cheap the current price of BOT stocks is, haha.
151820638 : When you delve deeper into this company, you will find that it has good products, a great team, a strong financial situation, and a vast market. The performance after half a year of commercialization will definitely bring you unexpected surprises!!!